Trials / Completed
CompletedNCT06298903
Impact of Hip Activation Compared to Hip Plus Balance Training on the Forward-Step-Down Test
The Effect of a Hip Activation Home Exercise Program (HEP) Compared to a Hip Activation + Single Leg Balance HEP on the Forward Step-Down Test in Healthy Females
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- Louisiana State University Health Sciences Center Shreveport · Academic / Other
- Sex
- Female
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this research is to determine the impact of a hip activation home exercise program (HEP) compared to a hip activation + single leg balance HEP on performance of the Forward-Step-Down Test (FSDT) in healthy females. Participants will be assigned to the control (hip activation HEP only) or experimental (hip activation + single leg balance HEP). Following the pre-test data collection, participants will complete their HEP for 8 weeks. They will return to the lab for post-test measurements.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Hip Activation | Sidelying hip abduction, side plank with hip abduction, clamshell (hip abduction + external rotation), side plan with clamshell, and quadruped fire hydrant exercises will be performed for 1 minute isometric holds, 2 times per week for 8 weeks. |
| OTHER | Hip activation + Single leg balance | Hip activation HEP: Sidelying hip abduction, side plank with hip abduction, clamshell (hip abduction + external rotation), side plan with clamshell, and quadruped fire hydrant exercises will be performed for 1 minute isometric holds, 2 times per week for 8 weeks. Single leg balance: variety of single leg balance exercises with different upper extremity and lower extremity positions to provide different balance stimuli. Weeks are alternated performing these exercises with eyes open and eyes closed. |
Timeline
- Start date
- 2024-01-12
- Primary completion
- 2024-03-25
- Completion
- 2024-08-01
- First posted
- 2024-03-07
- Last updated
- 2024-12-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06298903. Inclusion in this directory is not an endorsement.